C vs CRBU · P/E 16, rev $85.22B vs rev $10.0M
Citigroup Inc. (C) versus Caribou Biosciences Inc (CRBU) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported CRBU revenue for 2024-12-31 was $10.0M. Net income was -$149.1M. Revenue was down 71.0% from 2023-12-31 to 2024-12-31. CRBU currently screens at market cap $190.4M.
C currently screens at market cap $214.73B and trailing P/E 15.5. CRBU currently screens at market cap $190.4M.
Not investment advice. Open the C and CRBU stock pages for the full models.
Not investment advice.